white paper on translational research€¦ · translational research is patient-oriented and...
Post on 19-Jul-2020
1 Views
Preview:
TRANSCRIPT
Supported by: The European Union under
the 7th Framework Programme
Powered by: 1
WHITE PAPER ON
TRANSLATIONAL RESEARCH
IN OPHTHALMOLOGY AND VISION SCIENCES
IN THE EUROPEAN UNION
Supported by: The European Union under
the 7th Framework Programme
Powered by: 2
CONTENT
1. Definition ............................................................................................................4
2. Justification .........................................................................................................5
3. Clinical and Translational Research Institutions ..............................................................6
4. Clinical Research Networks ..................................................................................... 10
5. Coordinating Infrastructure..................................................................................... 12
6. Recommendations ................................................................................................ 13
Annex 1: List of European Translational Research Centres .................................................... 14
Supported by: The European Union under
the 7th Framework Programme
Powered by: 3
This White Paper is a deliverable of the Workpackage 5 “Re-engineering of clinical research,
including clinical trials, in the field of vision sciences” of the project “Visual Impairment and
Degeneration: A Road-map for Vision Research within Europe – EuroVisionNet” funded by the 7th
Framework Programme of the European Union.
This White Paper emerged from a group of European Centres with active programs integrating
Laboratory Research and dedicated Clinical Research Facilities in Vision and Ophthalmology.
The Centers were invited to participate in a Network “Translational Research Centres in
Ophthalmology and Vision Sciences” within the European Union. The purpose of this Network is to
stimulate the process for translational research between them and to synergize multidisciplinary and
interdisciplinary clinical and translational research.
Supported by: The European Union under
the 7th Framework Programme
Powered by: 4
1. Definition
Translational research, usually called “bench to bedside”, applies discoveries generated through
basic science research to the development and testing of preventive and treatment interventions
(i.e., services, programs, practices and products) and vice versa.
Translational research may be seen as a five-phase model of intervention research that is commonly
used to describe the continuum of biomedical research, from basic to applied science and vice versa.
Translational research is patient-oriented and implicates an approach to health research where there
is a permanent interchange between basic and applied science. Excellence in clinical research is a
fundamental component of good translational research. Clinical research raises the questions and
tests the proposed solutions.
The five phases of research, as applied to preventive intervention research across its life cycle,
include:
- epidemiology (identification of the problem or disorder and review of information to determine
its extent),
- disease-onset and disease progression (identification of risk and protective biomarkers for the
problem or disorder as potential targets for preventive intervention),
- intervention design, pilot testing, efficacy trials,
- effectiveness trials,
- dissemination trials.
The translation process and communication between the different partners must be an integral part
of all phases of research.
Supported by: The European Union under
the 7th Framework Programme
Powered by: 5
2. Justification
To improve human health, scientific discoveries must be translated into practical applications. Such
discoveries typically begin at “the bench” with basic research — in which scientists study disease at a
molecular or cellular level — then progress to the clinical level, or the patient's “bedside”. However,
questions raised at the “bedside” need also to be presented to molecular scientists.
Scientists are increasingly aware that this bench-to-bedside approach to translational research is
really a two-way street. Basic scientists provide clinicians with new tools for use in patients and for
assessment of their impact, and clinical researchers make novel observations about the nature and
progression of disease that should stimulate basic research.
Translational research has proven to be a powerful process that drives the clinical research engine.
However, a stronger clinical research infrastructure is necessary to strengthen and accelerate this
critical part of the clinical research enterprise. It is fundamental to create in the European Union the
right conditions for an even more successful process of translational research.
Supported by: The European Union under
the 7th Framework Programme
Powered by: 6
3. Clinical and Translational Research Institutions
Clinical and Translational Centres are needed to support research of clinical and translational science
and the needs of its researchers. They should be encouraged to propose novel concepts,
methodologies, and approaches that can be integrated into a comprehensive, effective, and efficient
researcher-, trainee-, and participant-centered program and develop their own list of key functions
and components of the Center.
Potential topics include:
- Development of Novel Clinical and Translational Methodologies
- Pilot and Collaborative Translational and Clinical Studies
- Development of Communication Pathways
- Implementation of Investigator-Driven Clinical Trials
- Centralized Support for Research Design, Epidemiology, Biostatistics and Clinical Research Ethics
- Regulatory Knowledge
- Research Education, Training and Career Development
- European Union Institutions
Each Centre should have clinical research resources, training programmes and regular access to basic
laboratory research. Research projects involving multiple aspects of health promotion, disease
prevention and treatment should be performed in active collaboration with other Centers in the same
area of scientific interest, e.g., Ophthalmology and Vision Health Care.
One or more Central Coordinating Core Centres must be set up and receive regular funding in order
to facilitate coordination between the individual centres.
The Centres are encouraged to make alliances and create partnerships with foundations, industry and
community organizations as appropriate, with all partners agreeing to follow European Union policies
with respect to 1) listing clinical trials at ClinicalTrials.gov; 2) sharing of resources; 3) data sharing
and public access and 4) establishing policies in support of investigator academic independence.
Development of Novel Clinical and Translational Methodologies
Original research on novel methodologies and approaches for translational and clinical sciences will
be needed if a Centre is to build an environment that sustains intellectual innovation. Areas in which
faculty should pursue funded research include new translational methodologies, methods for more
objective and quantifiable biomarkers or phenotyping, determining cost effectiveness, research into
clinical trial designs, clinical informatics for longitudinal studies, home based research devices and
methods, predictive toxicology in human populations and ethics research specific to populations.
Supported by: The European Union under
the 7th Framework Programme
Powered by: 7
Pilot and Collaborative Translational and Clinical Studies
New resources are generally required to determine whether the clinical potential of a promising
laboratory finding can be realized. Such funds must be available promptly and be accompanied by an
organizational structure that allows full compliance with regulatory requirements. Each Centre or
Network of Centres should be able to request support for pilot and collaborative clinical research
projects that:
- allow clinical and translational trainees or researchers to generate preliminary data for
submission of a research grant application
- address clinical trial design, novel biostatistics approaches, informatics and regulatory pathways;
- develop new technologies;
These pilot and collaborative projects should, in general, be of sufficient scope to qualify as a stand-
alone research effort and should be well integrated into the activities of the Centre.
Development of Communication Pathways
Biomedical informatics is the cornerstone of communication within Centres and with all collaborating
organizations. The Centres should consider both internal, intra-institution and external
interoperability to allow for communication among Centres and the necessary research partners of
clinical and translational investigators (e.g. government, clinical research networks, pharmaceutical
companies, commercial vendors, laboratories, and equipment manufacturers). Biomedical
informatics support in one or more centralized facilities is considered fundamental and must be
innovative taking into account interoperability, security, workflow, usability and standards are
essential areas of work.
The dissemination of knowledge concerning the role of translational research may be augmented
through the launch of on-line forums for free communication and exchange of ideas and through a
dedicated journal of translational ophthalmic research for the publication of related articles, letters
and reviews.
Implementation of Investigator-Driven Clinical Trials
It is well accepted that improving conditions for better investigator-driven clinical trials and clinical
research will translate into better patient care and health worldwide.
The top five recommendations to strengthen Investigator-Driven Clinical Trials (IDCT) in Europe as
ranked by a recent consensus conference were as follows:
1. To improve the education, training and career structure and opportunities for scientists
involved in patient-oriented clinical research
2. To increase levels of funding for IDCT
3. To adopt a ‘risk-based’ approach to the regulation of IDCT
4. To streamline procedures for obtaining authorisation for IDCT
Supported by: The European Union under
the 7th Framework Programme
Powered by: 8
5. To ensure that IDCT are carried out with an appropriate number of patients to produce
statistically reliable results so that the trials are ‘correctly powered’
These directions are considered a fundamental step towards effective translational research and they
include the need for one or more centralized facilities to support and coordinate the activities of
transnational investigator-driven clinical trials.
Centralized Support for Research Design, Epidemiology, Biostatistics and Clinical Research Ethics
Centralized support in trial design, biostatistics and clinical research ethics is necessary to
coordinate and support interactions between the individual Research Centres. Topics for research
involving this centralized facility might include, for example, limiting risk to participants, preventing
bias, improving recruitment and retention, developing innovative methods of enhancing the power of
studies, capturing appropriate data, developing design and analysis plans for studies of unique or
vulnerable populations or very small numbers of subjects, informed consent, and issues in diseases
with limited treatment options.
Regulatory Knowledge
Regulatory support for research teams will promote the protection of human subjects and facilitate
regulatory compliance. The Centres are encouraged to be innovative at all levels of clinical research
regulation including, for example, the provision of integrated training, services, or tools for protocol
and informed consent authoring and translation, adverse event reporting, safety and regulatory
management and compliance, etc. Centres could develop best practices that reduce or remove
institutional impediments to clinical and translational research and, through dissemination and
sharing, could enhance inter-institutional collaborations.
Communications with European Regulatory Authorities such as EMEA is considered an important step
forward by strengthen cooperation between Centres and the Central Office of EMEA.
Research Education, Training and Research Career Development
A key component of a Clinical and Translational Centre will be one or more graduate degree-granting
and post graduate programs in clinical and translational science that include a knowledge base for
clinical and translational researchers, irrespective of their primary interest, degree or discipline. In
response to the emergence of interdisciplinary, team-oriented environments, Centres should be
encouraged to train investigators from diverse disciplines as well as study coordinators, project
managers, and other key clinical research personnel in a range of topics relevant to clinical and
translational science (e.g., clinical research design, epidemiology, biostatistics, pharmacology,
biomedical informatics, ethics, behavioral science, engineering, law, health economics).
Supported by: The European Union under
the 7th Framework Programme
Powered by: 9
European Union Institutions
A major goal of this initiative is to develop a transnational Consortium of Clinical and Translational
Centres that will cooperatively address impediments to clinical and translational science and will
work toward adopting and implementing agreed-on best practices, policies, procedures, and other
measures to advance collaborative clinical and translational research and to reduce burden on
individual investigators at all institutions.
There is already a Network bringing together 72 Clinical Research Centres in Ophthalmology from 16
European countries, the EVICR.net - European Vision Institute Clinical Research Network that could
serve as an appropriate basis to promote and develop translational networking in Ophthalmology and
Vision Sciences across the European Union.
Supported by: The European Union under
the 7th Framework Programme
Powered by: 10
4. Clinical Research Networks
Because of the vast number of therapies, diagnostics and treatments that must be evaluated through
clinical trials, many clinical research networks operate simultaneously, but independently, of each
other. As a result, researchers must sometimes duplicate data that already exists because they are
unaware of the data or do not have access to the data. Standardizing data reporting would enable
seamless data- and sample-sharing across studies. By enhancing the efficiency of clinical research
networks through informatics and other technologies, researchers will be better able to broaden the
scope of their research. Reduced duplication of studies will leave more time and funds to address
additional research questions.
Clinical Research Network Inventory
The overall goal of this effort is to determine best practices in clinical research networks by
conducting an inventory of existing national networks. This project is examining organizational and
management structures of existing networks and will evaluate the types and volume of studies being
conducted. Other parameters to be analyzed include network performance, informatics
infrastructure and training procedures.
Integrating Clinical Research Networks
This initiative will test the feasibility of integrating and expanding existing clinical research
networks. A particular focus is on assessing the capacity for interoperability among networks. This
will broaden the kinds of research questions that can be addressed and will enhance the efficiency of
conducting clinical research. The long range goals are to develop networks that are based on
common infrastructure elements, such as informatics, governance and common language.
Clinical Research Training
One of the most important factors determining the health and vitality of the clinical research
enterprise is the scientific workforce. It is necessary to find ways to expand and diversify the clinical
research workforce by optimizing training and career development programs for the many necessary
players required to conduct successful clinical investigations. These players include physicians,
nurses, dieticians, epidemiologists, biostatisticians and informatics specialists. Tomorrow’s clinician
must be trained to work in the interdisciplinary, team-oriented environments that characterize
today’s emerging research efforts.
Ophthalmology residents should be exposed to training programmes in translational research and
translational research projects.
Supported by: The European Union under
the 7th Framework Programme
Powered by: 11
Visits of resident ophthalmologists or fellows at basic research centers should be encouraged or even
financed. Similarly, visits of basic scientists to Ophthalmic Departments and Eye Hospitals should
also be encouraged.
The clinical research workforce must be sufficient large to catalyze the translation of research
discoveries to patient care at the community level.
Supported by: The European Union under
the 7th Framework Programme
Powered by: 12
5. Coordinating Infrastructure
The EVICR.net - European Vision Institute Clinical Research Network is a network of European
Ophthalmological Clinical Research Centres dedicated to perform multinational clinical research
trials with the highest standards of quality, following the European and International Directives for
Clinical Trial Research. At present, EVICR.net has 72 Centres members from 16 European countries.
This network should serve as the basis for promoting and consolidating clinical research networking in
the European Union. Furthermore, most of the proposed Centres that were identified as having the
necessary requirements to become a Clinical and Translational Research Centres Network in
Ophthalmology and Vision Sciences are already part of this Network. Therefore, EVICR.net could
serve as the nucleus for innovative re-engineering of clinical research in Ophthalmology and Vision
Sciences within the European Union.
A major initial step involves a complete inventory of the different participating Centres, their
resources in personnel and equipment, their scientific productivity and their internationalization by
partnerships with other similar institutions in the world. This inventory will help identify the
available resources, how they could be synergized and the weaknesses that should be corrected.
EVICR.net offers an established basis for further development of improved organizational
management structures. It has organizational Standard Operating Procedures (SOPs) and independent
procedures for certification and quality control of the participating Centres.
EVICR.net has already established a Coordinating Infrastructure at AIBILI, in Coimbra, Portugal, to
support Investigator-Driven Clinical Trials, functioning as a not-for-profit contract organization and
creating the necessary conditions for efficient academic led trials. Appropriate recognition and
funding is needed to consolidate this type of Coordinating Infrastructure.
A major final goal is to extend these networking activities to affiliated centres in each European
Union region thus contributing progressively to spread harmonized information, governance,
scientific language and training activities. This extension of networking in the different European
regions will necessarily create a major organization that will produce a volume of scientific response
expected to compete favourably with any other region of the world and would certainly contribute to
strengthen European Union Health Industry and Innovation.
Supported by: The European Union under
the 7th Framework Programme
Powered by: 13
6. Recommendations
Several areas were identified in which the practice of translational research can be strengthened,
including the following:
Nurture team science
- Provide incentives for investigators engaged in team science associating laboratory science with
clinical science. Changes in the culture of academic medical centers need to be stimulated to
accomplish this.
- Provide project management functions, such as access to a “concierge” function, which serves as
a “one stop shop” for research support by supporting a coordinating centralised infrastructure.
- Provide training to investigators in project management and leadership skills.
- The European Union Research Programme should develop and improve grant mechanisms that
specifically support translational research teams associating laboratory science with clinical
science.
- Enhance and continue to emphasize the mentoring function of active Clinical and Translational
Centres.
- Find innovative ways to support research projects that are poised to move from the basic
research stage to first tests in humans.
Improve understanding of and access to technology transfer functions
- Enhance investigators’ understanding of the patent process, including disclosures and patent
costs.
- Standardize technology transfer functions and methods across institutions.
- Promote training for early career investigators regarding collaborations with industry.
Regular funding of a Coordinating Centralised Infrastructure
- A coordinating infrastructure is essential for successful Investigator-driven clinical trials and is
necessary to expand the ability to share resources across the active Clinical and Translational
Centres, including shared core facilities.
Improve access to technologies and animal models.
- Increase the number and/or access to technologies and animal models specifically related to drug
development.
- Develop a centralized database of animal models.
- Support development of instrument prototypes.
Supported by: The European Union under
the 7th Framework Programme
Powered by: 14
Annex 1: List of European Translational Research Centres
Austria
- Department of Ophthalmology, Medical University of Vienna, Vienna
Belgium
- Department of Ophthalmology, University Hospital Antwerp, Antwerp
France
- Centre d’Investigation Clinique, Centre National d’Ophtalmologie des Quinze-Vingts, Paris
- Service d'Ophtalmologie, Hôpital Purpan, Toulouse
Germany
- Department of Ophthalmology, University Medical Center, Johannes Gutenberg-University Mainz,
Mainz
- Steinbeis-Transfer - Centre for Biomedical Optics and Function Testing (STZ), Centre for
Ophthalmology, Tuebingen
- Department of Ophthalmology, University of Bonn, Bonn
- Department of Ophthalmology, University of Freiburg, Freiburg
- University Eye Hospital Leipzig, Leipzig
- Center for Vision Science, University Eye Clinic Bochum, Bochum
- Eye Centre Spreebogen, Berlin
Greece
- Institute of Vision and Optics (IVO), Crete
- Laboratory of Research and Clinical Applications in Ophthalmology, Department of
Ophthalmology, Thessalonik
Italy
- G.B.Bietti Eye Foundation – IRCCS, Rome
- Institute of Ophthalmology, Catholic University, Rome
- Sezione di Oftalmologia, Dipartimento di Scienze Otorino-Odonto-Oftalmologiche e Cervico
Facciali, Parma
Portugal
- AIBILI - Association for Innovation and Biomedical Research on Light and Image / Ophthalmology
Department - University Hospital of Coimbra, Coimbra, Portugal
Supported by: The European Union under
the 7th Framework Programme
Powered by: 15
Spain
- IOBA - Instituto Universitario de Oftalmobiologia Aplicada, Valladolid
- VISSUM - Instituto Oftalmológico de Alicante, Alicante
- Institut Català de Retina (ICR), Barcelona
Switzerland
- Department of Ophthalmology, Inselspital, University of Bern, Bern
- Jules Gonin Eye Hospital, Department of Ophthalmology, Lausanne
The Netherlands
- Department of Ophthalmology, Academic Medical Center, Amsterdam
- Rotterdam Eye Hospital, Rotterdam
United Kingdom
- Clinical Trials Unit and Reading Centre, Moorfields Eye Hospital, NHS Foundation Trust, London
- Clinical Eye Research Centre, Royal Liverpool University Hospital, Liverpool
Supported by: The European Union under
the 7th Framework Programme
Powered by: 16
POWERED BY
AIBILI – ASSOCIATION FOR INNOVATION AND BIOMEDICAL RESEARCH ON LIGHT AND IMAGE
ADDRESS: AZINHAGA STA. COMBA, CELAS, 3000-548 COIMBRA, PORTUGAL
TELEPHONE: +351239480100 | FAX: +351239480117 | E-MAIL: aibili@aibili.pt
top related